1992
DOI: 10.1111/j.1600-0625.1992.tb00185.x
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous absorption of azelaic acid in humans

Abstract: Six healthy male volunteers received a single topical treatment with 5 g of an anti-acne cream containing 20% azelaic acid (AzA) onto the face, the chest and the upper back. One week later 1 g of AzA was given orally to the same subjects as aqueous microcrystalline suspension. Following the two treatments the renal excretion of the unchanged compound was measured. Analysis included ether extraction of the urine, derivatization of extract and HPLC with UV detection. After topical application 2.2 +/- 0.7%, and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0
5

Year Published

1995
1995
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 12 publications
0
13
0
5
Order By: Relevance
“…Azelaic acid Azelaic acid is a dicarboxylic acid which is naturally present in the organism [479,480] and is not teratogenic [472,475,476]. The percutaneous rate of absorption is 3.6% [481].…”
Section: Topical Preparations For the Treatment Of Acne Which May Be mentioning
confidence: 99%
“…Azelaic acid Azelaic acid is a dicarboxylic acid which is naturally present in the organism [479,480] and is not teratogenic [472,475,476]. The percutaneous rate of absorption is 3.6% [481].…”
Section: Topical Preparations For the Treatment Of Acne Which May Be mentioning
confidence: 99%
“…Following the single topical application of azelaic acid 20% cream to the face, chest and upper back of six healthy male volunteers, percutaneous absorption of azelaic acid was 3.6% of the dermally applied dose; 2.2% of the dose was excreted unchanged in the urine [40]. When administered orally, 61.2% of a 1-g dose was excreted unchanged in the urine of the same volunteers.…”
Section: Pharmacokineticsmentioning
confidence: 96%
“…12 Após a aplicação tópica de ácido azeláico, cerca de 4% do fármaco é absorvido para a circulação sistémica, mas estudos em modelos animais não mostraram teratogenicidade (categoria de risco B pela FDA). 79 Não existem estudos relativos à sua utilização durante a amamentação, mas pela fraca absorção sistémica o seu uso parece ser seguro durante a lactação. 19,80 A aplicação local de azoto líquido e de ácido tricloroacé-tico são considerados tratamentos de eleição para verrugas víricas e condilomas acuminados em grávidas.…”
Section: Outrosunclassified